GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OTCPK:GNGBF) » Definitions » Ending Cash Position

Getinge AB (Getinge AB) Ending Cash Position : $323 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Getinge AB Ending Cash Position?

Getinge AB's Ending Cash Position for the quarter that ended in Mar. 2024 was $323 Mil.

Getinge AB's quarterly Ending Cash Position declined from Sep. 2023 ($481 Mil) to Dec. 2023 ($266 Mil) but then increased from Dec. 2023 ($266 Mil) to Mar. 2024 ($323 Mil).

Getinge AB's annual Ending Cash Position increased from Dec. 2021 ($448 Mil) to Dec. 2022 ($547 Mil) but then declined from Dec. 2022 ($547 Mil) to Dec. 2023 ($266 Mil).

Getinge AB Ending Cash Position Historical Data

The historical data trend for Getinge AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Ending Cash Position Chart

Getinge AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 132.95 724.13 448.43 546.93 265.95

Getinge AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 441.47 411.73 481.47 265.95 322.53

Getinge AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Getinge AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=553.346+-287.397
=266

Getinge AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=262.119+60.415
=323

Getinge AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Getinge AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Getinge AB (Getinge AB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OTCPK:GNGBF) » Definitions » Ending Cash Position
Comparable Companies
OSTO:SECT B OSTO:VITR OSTO:XVIVO OSTO:CEVI OSTO:MCAP OSTO:BICO OSTO:BACTI B OSTO:SEDANA OSTO:CRAD B OSTO:INTEG B TSE:5212 ABT SYK MDT BSX EW DXCM SZSE:300760 ZBH ALGN
Traded in Other Exchanges
GNGBY:USA GETI B:Sweden GETIBs:UK 0GZV:UK GTN:Germany
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Website
https://www.getinge.com
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (54% of revenue), surgical workflows (32%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.